Sarcopenia

Low Muscle Mass and Treatment Tolerance in Patients With Upper Gastrointestinal Cancer: A Systematic Review and Meta-Analysis

A systematic review and meta-analysis of 49 studies looking at whether low skeletal muscle mass in people with upper gastrointestinal cancer having systemic treatment is linked to severe (grade 3–4) adverse events and to stopping treatment early. Low …

MUSCLE-CITE: Low skeletal muscle mass and Chemotherapy, Immunotherapy and Targeted therapy related toxicity in metastatic breast cancer

A retrospective cohort study of the association between low skeletal muscle mass, assessed from CT imaging, and chemotherapy, immunotherapy and targeted therapy related toxicity in patients with metastatic breast cancer.